Ubs Asset Management Americas Inc Novo Cure LTD Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 701,645 shares of NVCR stock, worth $13.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
701,645
Previous 907,999
22.73%
Holding current value
$13.5 Million
Previous $14.2 Million
47.33%
% of portfolio
0.01%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding NVCR
# of Institutions
290Shares Held
75.6MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$233 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$227 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$171 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$92.6 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$52.7 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.02B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...